Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N
Signal Transduct Target Ther. 2025; 10(1):11.
PMID: 39800748
PMC: 11734941.
DOI: 10.1038/s41392-024-02080-z.
Rautela U, Sarkar G, Chaudhary A, Chatterjee D, Rosh M, Arimbasseri A
PLoS Genet. 2024; 20(11):e1011453.
PMID: 39546504
PMC: 11602045.
DOI: 10.1371/journal.pgen.1011453.
Banerjee M, Pandey V
Curr Protein Pept Sci. 2024; 26(2):113-124.
PMID: 39225225
DOI: 10.2174/0113892037329528240827180820.
Disli S, Fidan E
Rev Assoc Med Bras (1992). 2023; 69(12):e20230680.
PMID: 37971123
PMC: 10645177.
DOI: 10.1590/1806-9282.20230680.
Boubertakh B, Courtemanche O, Marsolais D, Di Marzo V, Silvestri C
J Lipid Res. 2023; 64(11):100444.
PMID: 37730163
PMC: 10622703.
DOI: 10.1016/j.jlr.2023.100444.
Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting β cell differentiation.
Stamateris R, Landa-Galvan H, Sharma R, Darko C, Redmond D, Rane S
J Clin Invest. 2023; 133(18).
PMID: 37712417
PMC: 10503800.
DOI: 10.1172/JCI166490.
CDK6 is essential for mesenchymal stem cell proliferation and adipocyte differentiation.
Hu A, Li W, Pathak A, Hu G, Hou X, Farmer S
Front Mol Biosci. 2023; 10:1146047.
PMID: 37664186
PMC: 10469316.
DOI: 10.3389/fmolb.2023.1146047.
CDK4-E2F3 signals enhance oxidative skeletal muscle fiber numbers and function to affect myogenesis and metabolism.
Bahn Y, Yadav H, Piaggi P, Abel B, Gavrilova O, Springer D
J Clin Invest. 2023; 133(13).
PMID: 37395281
PMC: 10313363.
DOI: 10.1172/JCI162479.
The Challenges of Treating Patients with Breast Cancer and Obesity.
LeVee A, Mortimer J
Cancers (Basel). 2023; 15(9).
PMID: 37173991
PMC: 10177120.
DOI: 10.3390/cancers15092526.
Cell cycle regulators and bone: development and regeneration.
Shaikh A, Wesner A, Abuhattab M, Kutty R, Premnath P
Cell Biosci. 2023; 13(1):35.
PMID: 36810262
PMC: 9942316.
DOI: 10.1186/s13578-023-00988-7.
Repositioning of simvastatin for diabetic colon cancer: role of CDK4 inhibition and apoptosis.
Gajjar S, Bora V, Patel B
Mol Cell Biochem. 2023; 478(10):2337-2349.
PMID: 36703094
DOI: 10.1007/s11010-023-04663-w.
Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesity.
Kripa E, Rizzo V, Galati F, Moffa G, Cicciarelli F, Catalano C
Front Oncol. 2022; 12:987012.
PMID: 36212446
PMC: 9538503.
DOI: 10.3389/fonc.2022.987012.
The SREBP-dependent regulation of cyclin D1 coordinates cell proliferation and lipid synthesis.
Aldaalis A, Bengoechea-Alonso M, Ericsson J
Front Oncol. 2022; 12:942386.
PMID: 36091143
PMC: 9451027.
DOI: 10.3389/fonc.2022.942386.
CDK4: a master regulator of the cell cycle and its role in cancer.
Baker S, Poulikakos P, Irie H, Parekh S, Reddy E
Genes Cancer. 2022; 13:21-45.
PMID: 36051751
PMC: 9426627.
DOI: 10.18632/genesandcancer.221.
DEPP Deficiency Contributes to Browning of White Adipose Tissue.
Guo F, Zhu Y, Han Y, Feng X, Pan Z, He Y
Int J Mol Sci. 2022; 23(12).
PMID: 35743009
PMC: 9223522.
DOI: 10.3390/ijms23126563.
The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers?.
Benot-Dominguez R, Cimini A, Barone D, Giordano A, Pentimalli F
Cancers (Basel). 2022; 14(11).
PMID: 35681689
PMC: 9179653.
DOI: 10.3390/cancers14112709.
Expression of the preadipocyte marker ZFP423 is dysregulated between well-differentiated and dedifferentiated liposarcoma.
Dang T, Tiongco R, Brown L, Taylor J, Lyons J, Lau F
BMC Cancer. 2022; 22(1):300.
PMID: 35313831
PMC: 8939188.
DOI: 10.1186/s12885-022-09379-6.
Transcriptional and DNA Methylation Signatures of Subcutaneous Adipose Tissue and Adipose-Derived Stem Cells in PCOS Women.
Divoux A, Erdos E, Whytock K, Osborne T, Smith S
Cells. 2022; 11(5).
PMID: 35269469
PMC: 8909136.
DOI: 10.3390/cells11050848.
Perspectives on scaling production of adipose tissue for food applications.
Yuen Jr J, Stout A, Kawecki N, Letcher S, Theodossiou S, Cohen J
Biomaterials. 2021; 280:121273.
PMID: 34933254
PMC: 8725203.
DOI: 10.1016/j.biomaterials.2021.121273.
Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives.
Barone I, Caruso A, Gelsomino L, Giordano C, Bonofiglio D, Catalano S
Obes Rev. 2021; 23(2):e13358.
PMID: 34559450
PMC: 9285685.
DOI: 10.1111/obr.13358.